HHS agrees to delay drug rebate rule

(By Maia Anderson for Becker’s Hospital Review)

HHS has agreed to postpone by one year the start date of a rule it passed last November that would eliminate the rebates drugmakers pay to pharmacy benefit managers.

The rule was postponed from its original start date of Jan. 1, 2022, to Jan. 1, 2023, according to a court document filed Jan. 30. It was passed by HHS last November as an attempt to simplify drug pricing and pass discounts to consumers. Drugmakers have supported the rule, while PBMs have opposed it.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org